Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Revenue $23.0K $164.0K $29.0K $21.0K $103.0K $297.0K $73.0K $123.0K
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $21.4M $18.4M $16.5M $12.9M $13.8M $15.6M $7.4M $6.7M
Operating Income $-54.3M $-47.6M $-52.0M $-40.1M $-42.0M $-39.9M $-28.0M $-28.7M
Operating Margin -236,039.1% -29,031.7% -179,141.4% -190,914.3% -40,729.1% -13,450.5% -38,323.3% -23,313.0%
Interest Expense $2.3M $2.1M $2.0M $1.9M $2.0M $1.8M $1.6M $1.5M
Pretax Income — — — — — — — —
Income Tax Expense — — — — — — — —
Net Income $-52.0M $-44.8M $-49.2M $-38.1M $-42.6M $-41.1M $-28.1M $-30.1M
Net Margin -225,969.6% -27,320.1% -169,748.3% -181,533.3% -41,393.2% -13,821.9% -38,516.4% -24,469.9%
EPS (Basic) $-0.08 $-0.08 $-0.09 $-0.07 $-0.11 $-0.10 $-0.07 $-0.09
EPS (Diluted) $-0.08 $-0.08 $-0.09 $-0.07 $-0.11 $-0.10 $-0.07 $-0.09
Shares Outstanding (Basic) 570.6M 579.5M 547.3M 544.5M 380.8M 405.2M 403.9M 332.1M
Shares Outstanding (Diluted) 570.6M 579.5M 547.3M 544.5M 380.8M 405.2M 403.9M 332.1M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 8 Older →